Is NCVLX or SBUX a better dividend investment in 2026?

NCVLX currently yields 1.73% with a 5% 5-year dividend growth rate. SBUX yields 2.75% with 5% growth. The better choice depends on your goal: SBUX offers higher current income.

What is the dividend yield difference between NCVLX and SBUX?

NCVLX has a forward dividend yield of 1.73% ($0.22/share annually). SBUX yields 2.75% ($2.46/share annually). The yield gap is 1.02 percentage points.

Home › Compare › NCVLX vs SBUX

NCVLX vs SBUX: Dividend Comparison 2026

NCVLX yields 1.73% · SBUX yields 2.75%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SBUX wins by $135.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

NCVLX

● Live price

1.73%

Share price

$12.61

Annual div

$0.22

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.2K

Annual income

$193.32

Full NCVLX calculator →

SBUX

● Live price

2.75%

Share price

$89.59

Annual div

$2.46

5Y div CAGR

48.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$157.5K

Annual income

$65,840.13

Full SBUX calculator →

Portfolio growth — NCVLX vs SBUX

📍 SBUX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NCVLX	SBUX
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NCVLX + SBUX cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NCVLX pays

SBUX pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NCVLX

Annual income on $10K today (after 15% tax)

$146.93/yr

After 10yr DRIP, annual income (after tax)

$164.32/yr

SBUX

Annual income on $10K today (after 15% tax)

$233.40/yr

After 10yr DRIP, annual income (after tax)

$55,964.11/yr

At 15% tax rate, SBUX beats the other by $55,799.79/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NCVLX + SBUX for your $10,000?

NCVLX: 50%SBUX: 50%

100% SBUX50/50100% NCVLX

Portfolio after 10yr

$89.9K

Annual income

$33,016.72/yr

Blended yield

36.74%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

NCVLX

No analyst data

SBUX

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$104.00

+16.1% upside vs current

Range: $90.00 — $120.00

Altman Z

2.6

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NCVLX buys

SBUX buys

No recent congressional trades found for NCVLX or SBUX in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNCVLXSBUX

Forward yield	1.73%	2.75% ✓
Annual dividend / share	$0.22	$2.46 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	48.3% ✓
Portfolio after 10y	$22.2K	$157.5K ✓
Annual income after 10y	$193.32	$65,840.13 ✓
Total dividends collected	$1.8K	$127.5K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: NCVLX vs SBUX ($10,000, DRIP)

Year	NCVLX Portfolio	NCVLX Income/yr	SBUX Portfolio	SBUX Income/yr	Gap
1← crossover	$10,873	$172.85	$11,107	$407.21	$234.00 → SBUX
2	$11,810	$175.65	$12,512	$626.87	$702.00 → SBUX
3	$12,815	$178.30	$14,366	$978.69	$1.6K → SBUX
4	$13,892	$180.81	$16,929	$1,557.50	$3.0K → SBUX
5	$15,048	$183.20	$20,658	$2,543.80	$5.6K → SBUX
6	$16,287	$185.46	$26,406	$4,302.22	$10.1K → SBUX
7	$17,615	$187.59	$35,877	$7,622.00	$18.3K → SBUX
8	$19,037	$189.61	$52,741	$14,352.64	$33.7K → SBUX
9	$20,561	$191.52	$85,676	$29,243.03	$65.1K → SBUX
10	$22,194	$193.32	$157,513	$65,840.13	$135.3K → SBUX

NCVLX vs SBUX: Complete Analysis 2026

NCVLX — Stock

The fund invests primarily in common stocks of companies organized in the United States that the Adviser believes are high quality, though temporarily out of favor. It typically invests in a portfolio of 15 to 35 companies of various market capitalizations and is considered an all-cap strategy. Although the fund will invest primarily in the common stocks of U.S. companies, the fund may invest up to 25% of its assets in ADRs or common stocks of foreign companies that are classified as "developed" by MSCI Inc. It is non-diversified.

Full NCVLX Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →

📬

Get this NCVLX vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NCVLX vs SCHD NCVLX vs JEPI NCVLX vs O NCVLX vs KO NCVLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.